Karyopharm Therapeutics Inc. · NASDAQ:KPTI
Rangwala Reshma sold 408 Karyopharm Therapeutics Inc. shares (Form 4)
Traded May 13 to May 14, 2026 · Filed May 15, 2026
From May 13 to May 14, 2026, Rangwala Reshma (EVP & Chief Medical Officer) sold 408 Karyopharm Therapeutics Inc. shares at US$9.50 for US$3,876, leaving 56,829 shares. Filed May 15, 2026 (Form 4).
- Sold
- 408 shares
- Price
- US$9.50
- Value
- US$3,876
- Holding after
- 56,829 shares
- Trading plan
- No
- Role
- EVP & Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 13, 2026 | Common Stock | Award | 947 | 57,237 | Direct | |
| May 14, 2026 | Common Stock | Sale | 408 | US$9.50 | 56,829 | Direct |
Source
Related
- Karyopharm Therapeutics Inc.
- Rangwala Reshma
- Karyopharm Therapeutics Inc. shareholders
- Form 4 · Rangwala Reshma · Apr 22, 2026
- Form 4 · Abate Kristin · Oct 19, 2026
- Schedule 13G/A · Anders Hove · Oct 8, 2026
- Form 4 · Abate Kristin · Oct 2, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026
- Schedule 13G/A · Anders Hove · Sep 25, 2026